Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Gilead (GILD) Announces OS Data on Yescarta From ZUMA-7 Study
04:01pm, Wednesday, 22'nd Mar 2023
Gileads Yescarta shows statistically significant improvement in overall survival for initial treatment of R/R LBCL patients versus historical standard of care in curative setting.
A Bull Market Is Coming: Load Up On These 3 Cheap Stocks Today
10:07am, Wednesday, 22'nd Mar 2023
Alibaba is coming off an encouraging quarter, and there are more opportunities for it to get stronger. Comcast is a diversified business that should be in a good position to continue performing well.
Gilead (GILD) Exercises Option to License Nurix's Candidate
04:01pm, Tuesday, 21'st Mar 2023
Gilead (GILD) exercises an option under its collaboration agreement with Nurix to license the latter???s investigational targeted protein degrader molecule NX 0479.
Nurix's stock rallies on Gilead's option
09:00am, Monday, 20'th Mar 2023
Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercised the option to exclusively license Nurix's target
Gilead (GILD) Gains 34% in 12 Months: Will the Trend Sustain?
01:46pm, Thursday, 16'th Mar 2023
Gilead (GILD) gains 34% in the past 12 months as its HIV business and rapidly growing oncology business maintain momentum despite volatility.
Gilead Sciences: Underlying Growth Obscured By Veklury Swings
02:00pm, Thursday, 09'th Mar 2023
Gilead Sciences got very lucky with its Veklury anti-viral, as it proved very valuable in combating Covid-19. Meanwhile, Gilead management has been working to transform the business from a declining c
U.S. Wide-Moat Stocks On Sale - The March 2023 Heat Map
03:09am, Wednesday, 08'th Mar 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Gilead Sciences, Inc. (GILD) Presents at Cowen 43rd Annual Healthcare Conference (Transcript)
02:16pm, Tuesday, 07'th Mar 2023
Gilead Sciences, Inc. (NASDAQ:GILD ) Cowen 43rd Annual Healthcare Conference March 7, 2023 11:10 AM ET Company Participants Andy Dickinson - Chief Financial Officer Conference Call Participants Tyler
Analyst Expectations for Gilead Sciences's Future
03:00pm, Monday, 06'th Mar 2023 Benzinga
Over the past 3 months, 11 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
10:45pm, Friday, 03'rd Mar 2023 Zacks Investment Research
Gilead Sciences (GILD) closed the most recent trading day at $81.07, moving +1.82% from the previous trading session.
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
11:20am, Monday, 27'th Feb 2023 Zacks Investment Research
Sector ETF report for PBE
7 Cash-Rich Companies to Invest in During Economic Uncertainty
02:12pm, Sunday, 26'th Feb 2023
While it's generally good to be optimistic, in the market, it also pays to be realistic, thus incentivizing consideration for cash-rich stocks to buy. Here, we're not necessarily talking about the mos
3 Stocks to Buy Right Now That Are Cash Cows
11:25am, Saturday, 25'th Feb 2023 The Motley Fool
If cash is king, these three stocks should wear crowns.
WHO panel is reviewing whether COVID vaccines need to be updated
06:01pm, Friday, 24'th Feb 2023 MarketWatch
Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
11:20am, Friday, 24'th Feb 2023 Zacks Investment Research
Smart Beta ETF report for SPHD
